**Background of eIF5 Antibody**
The eukaryotic translation initiation factor 5 (eIF5) is a critical regulatory protein involved in the initiation phase of protein synthesis. It plays a key role in ensuring accurate start codon selection by promoting GTP hydrolysis by eIF2 within the 48S pre-initiation complex, a step essential for ribosomal subunit joining and transition to elongation. eIF5 interacts with other initiation factors, such as eIF2 and eIF3. to coordinate the assembly and disassembly of translation initiation complexes. Dysregulation of eIF5 has been implicated in cellular stress responses, cancer progression, and neurological disorders, highlighting its importance in maintaining translational fidelity and cellular homeostasis.
Antibodies targeting eIF5 are valuable tools for studying its expression, localization, and functional interactions in various biological contexts. These antibodies enable researchers to investigate eIF5's role in normal and pathological conditions through techniques like Western blotting, immunofluorescence, and co-immunoprecipitation. Specific eIF5 antibodies can distinguish between phosphorylated or modified forms, aiding in the exploration of post-translational regulation. Commercial eIF5 antibodies are typically raised against conserved epitopes, ensuring cross-reactivity across species like humans, mice, and rats. Recent studies using eIF5 antibodies have shed light on its involvement in stress granule formation, tumorigenesis, and viral infection mechanisms, underscoring its multifaceted contributions to cellular physiology.